-

Alphatec Holdings, Inc. (ATEC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (NASDAQ: ATEC) investors concerning the Company’s possible violations of federal securities laws.

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ALPHATEC HOLDINGS, INC. (ATEC), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.

Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@howardsmithlaw.com, by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com.

What Happened?

On May 5, 2026, Alphatec released its first quarter 2026 financial results, missing consensus estimates in revenue and stating that “deliveries were lower than the prior year period, resulting in lower revenue recognition for the quarter.” The Company also reduced its full year 2026 EOS revenue outlook, disclosing that EOS “installation timing was a challenge in the quarter” and that the Company had “committed to a number of units” that it “did not fulfill.”

On this news, Alphatec’s stock price fell $3.24, or 31.7%, to close at $6.99 per share on May 6, 2026, thereby injuring investors.

Contact Us To Participate or Learn More:

If you purchased Alphatec securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:

Law Offices of Howard G. Smith,
3070 Bristol Pike, Suite 112,
Bensalem, Pennsylvania 19020,
Telephone: (215) 638-4847
Email: howardsmith@howardsmithlaw.com,
Visit our website at: www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

Law Offices of Howard G. Smith

NASDAQ:ATEC

Release Versions

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

More News From Law Offices of Howard G. Smith

Securities Fraud Class Action Lawsuit Pending Against Lululemon Athletica, Inc: The Law Offices of Howard G. Smith Highlights Lead Plaintiff Deadline

BENSALEM, Pa.--(BUSINESS WIRE)--Lululemon Athletica, Inc ("Lululemon" or the "Company") (NASDAQ: LULU) is the subject of a securities fraud class action lawsuit filed on behalf of investors who purchased or otherwise acquired the Company's securities from March 18, 2026 through September 3, 2026, inclusive. The Law Offices of Howard G. Smith today reported the lawsuit, Koronczi v. lululemon athletica inc. et al., which was filed on November 2, 2026 in the U.S. District Court New Jersey District...

Deadline Alert: O-I Glass, Inc. Stockholders Face December 28, 2026 Lead Plaintiff Deadline in Securities Fraud Class Action, The Law Offices of Howard G. Smith Highlights

BENSALEM, Pa.--(BUSINESS WIRE)--O-I Glass, Inc. ("O-I Glass" or the "Company") (NYSE: OI) investors who wish to serve as lead plaintiff in a pending securities fraud class action lawsuit must move the Court by December 28, 2026. The suit was filed on behalf of investors who purchased or otherwise acquired the Company's securities from March 14, 2025 through July 28, 2026, inclusive. The Law Offices of Howard G. Smith today highlighted the deadline in the case, Bryan v. O-I Glass, Inc. et al., wh...

Did You Lose Money on Madrigal Pharmaceuticals, Inc. Stock? The Law Offices of Howard G. Smith Announces Securities Fraud Investigation After 8.1% Share Price Decline

BENSALEM, Pa.--(BUSINESS WIRE)--Investors who suffered losses on Madrigal Pharmaceuticals, Inc. ("Madrigal" or the "Company") stock may have claims to recover those losses. The Law Offices of Howard G. Smith today reported that it is conducting a securities fraud investigation on behalf of Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) investors into whether the Company may have violated the federal securities laws. The investigation comes after a November 3, 2026 disclosure concerning Madrigal P...
Back to Newsroom